Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001193125-26-006435

Options or other derivatives

  • Director acquired 240,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jain Rita · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-05 Grant or award : show line 1 in the form Stock Option (right to buy) +240,000 240,000 D
Loading xslF345X05/ownership.xml…